Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

Your institution is subscribed to Read Institutional Edition. Log in or Sign Up to read full text articles.

JOURNAL ARTICLE

REVIEW

The management of psychosis in movement disorder patients

Kelvin L Chou, Leora L Borek, Joseph H Friedman

Expert Opinion on Pharmacotherapy 2007, 8 (7): 935-43

Psychosis may be seen with several movement disorders. As pharmacological treatments can sometimes worsen movement disorders, psychosis in these situations can be complex for clinicians to manage. This review covers the management of psychosis in three different movement disorders: Parkinson's disease, dementia with Lewy bodies and Huntington's disease.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Daniel Weintraub, Howard I Hurtig American Journal of Psychiatry 2007, 164 (10): 1491-8

Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms. Andrius Baskys Journal of Clinical Psychiatry 2004, 65 Suppl 11: 16-22

Clozapine and risperidone treatment of psychosis in Parkinson's disease. T Ellis, M E Cudkowicz, P M Sexton, J H Growdon Journal of Neuropsychiatry and Clinical Neurosciences 2000, 12 (3): 364-9

Pharmacologic management of psychosis in the elderly: a critical review. Nicholas Hoeh, Laszlo Gyulai, Daniel Weintraub, Joel Streim Journal of Geriatric Psychiatry and Neurology 2003, 16 (4): 213-8

The emerging role of clozapine in the treatment of movement disorders. S A Factor, J H Friedman Movement Disorders: Official Journal of the Movement Disorder Society 1997, 12 (4): 483-96

Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. Hubert H Fernandez, Martha E Trieschmann, Monica A Burke, Joseph H Friedman Journal of Clinical Psychiatry 2002, 63 (6): 513-5

Atypical antipsychotics in Parkinson-sensitive populations. Joseph H Friedman, Hubert H Fernandez Journal of Geriatric Psychiatry and Neurology 2002, 15 (3): 156-70

Use of risperidone in psychosis associated with Huntington's disease. S Madhusoodanan, R Brenner American Journal of Geriatric Psychiatry 1998, 6 (4): 347-9

Clozapine therapy for Parkinson's disease and other movement disorders. C Pfeiffer, M L Wagner American Journal of Hospital Pharmacy 1994 December 15, 51 (24): 3047-53

Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients. M L Wagner, J L Defilippi, M A Menza, J I Sage Journal of Neuropsychiatry and Clinical Neurosciences 1996, 8 (3): 276-80

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

The management of psychosis in movement disorder patients

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips